Health | Fortune

Skip to Content

NEW

A vastly improved search engine helps you find the latest on companies, business leaders, and news more easily.

SIGN IN

Finance
McKinsey agrees to yet another mammoth opioids payment, this time to settle Nevada probe
By
Michelle L. Price
and
The Associated Press
March 23, 2021
Newsletters
AT&T chair Bill Kennard: ‘Legacy businesses have to disrupt themselves’
By
Alan Murray
and
David Meyer
March 23, 2021
Health
AstraZeneca’s U.S. COVID trial in doubt after agency says drugmaker may have submitted outdated data
By
Michelle Fay Cortez,
Jason Gale,
and others
March 23, 2021
Newsletters
The future of collaboration
By
Alan Murray
and
David Meyer
March 22, 2021
Health
AstraZeneca COVID-19 vaccine was 79% effective in U.S. trial, paving way for potential approval
By
Bloomberg
March 22, 2021
Retail
Krispy Kreme will offer free doughnuts—all year long—to people with COVID-19 vaccination cards
By
Chris Morris
March 22, 2021
Health
How rapid COVID vaccine rollouts ‘backfired’ in some U.S. states
By
Carla K. Johnson,
Nicky Forster,
and others
March 22, 2021
International
China has secured 100 million doses of BioNTech’s vaccine. Why hasn’t it approved the jab yet?
By
Grady McGregor
March 20, 2021
Health
Pregnant women aren’t typically included in clinical trials, but that’s changing with COVID
By
Sy Mukherjee
March 19, 2021
Health
CDC says three feet between students is now sufficient
By
Chris Morris
March 19, 2021
Health
Only 6 states lack COBRA-like benefits for laid-off small-business employees. That soon may change in Montana
By
Sara Reardon
and
Kaiser Health News
March 19, 2021
International
‘Virus metrics are getting uglier’: Why COVID-ravaged Europe is locking down again
By
Bernhard Warner
March 19, 2021
Health
European stocks slip as coronavirus variants force retreat into lockdown
By
David Meyer
March 19, 2021
Newsletters
Friday feedback: Parsing the Danone drama
By
Alan Murray
and
David Meyer
March 19, 2021

1 - 14 of 6,689 results

1 - 14 of 6,689 results

© 2020 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell My Personal Information | Ad Choices
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.
Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual Fund data provided by Morningstar, Inc. Dow Jones Terms & Conditions: http://www.djindexes.com/mdsidx/html/tandc/indexestandcs.html.
S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.